Reply to E.M. Ruggeri et al and Y.-W. Hu

Affiliations

¹ Tisch Cancer Institute, Icahn School of Medicine, New York, NY matthew.galsky@mssm.edu.
² Icahn School of Medicine at Mount Sinai, New York, NY.

Comment

Matthew D Galsky et al. J Clin Oncol. 2016.

. 2016 Sep 10;34(26):3225-6.

doi: 10.1200/JCO.2016.68.3052. Epub 2016 Jul 11.

¹ Tisch Cancer Institute, Icahn School of Medicine, New York, NY matthew.galsky@mssm.edu.
² Icahn School of Medicine at Mount Sinai, New York, NY.

No abstract available

Comment on

Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer.
Galsky MD, Stensland KD, Moshier E, Sfakianos JP, McBride RB, Tsao CK, Casey M, Boffetta P, Oh WK, Mazumdar M, Wisnivesky JP. Galsky MD, et al. J Clin Oncol. 2016 Mar 10;34(8):825-32. doi: 10.1200/JCO.2015.64.1076. Epub 2016 Jan 19. J Clin Oncol. 2016. PMID: 26786930
Should We Use Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer After Radical Cystectomy?
Ruggeri EM, Fabbri MA, Nelli F. Ruggeri EM, et al. J Clin Oncol. 2016 Sep 10;34(26):3223. doi: 10.1200/JCO.2016.67.5132. Epub 2016 Jul 11. J Clin Oncol. 2016. PMID: 27400940 No abstract available.
Real-World Role of Adjuvant Chemotherapy in Bladder Cancer.
Hu YW. Hu YW. J Clin Oncol. 2016 Sep 10;34(26):3224. doi: 10.1200/JCO.2016.67.5884. Epub 2016 Jul 11. J Clin Oncol. 2016. PMID: 27400950 No abstract available.